Parkinson's Disease and Parkinsonism Clinical Trial
Official title:
Safety and Efficacy of Personalized Repetitive Transcranial Magnetic Stimulation Protocol Based on Functional Reserve to Enhance Ambulatory Function in Patients With Parkinson Disease
The objective of this study was to determine the effects of protocols of repetitive transcranial magnetic stimulation (rTMS) therapy based on the functional reserve of each patient with Parkinson's disease, compared to conventional high-frequency rTMS therapy on bilateral primary motor cortex (M1). Investigators hypothesized that the functional reserve of each patient with Parkinson's disease will be different, and therefore an appropriate simulating target for rTMS therapy is needed. In addition, this approach could be more effective compared to conventional protocols applied to patient with Parkinson's disease regardless of their severity, predicted mechanism of motor function recovery, or functional reserves.
rTMS treatment for patients with Parkinson's disease is traditionally based on stimulating the neural network of brain. The widely-used traditional rTMS treatment protocol involves high-frequency stimulation over the bilateral primary motor cortex (M1) to enhance motor and gait functions. However, concerns have arisen regarding the effect of rTMS on motor recovery in patients with Parkinson's disease. Although still subject to debate, a possible reason for the diverse results of rTMS applied is the uniform application protocol to individuals with varying pathologies and functional reserves, aimed at enhancing recovery. Therefore, this study was aimed to determine the effects of protocols of rTMS therapy based on the functional reserve of each patient with Parkinson's disease. Based on screening evaluations (Timed Up and Go Test (TUG), Timed Up and Go Dual Task-Cognitive (TUG-Cog)), investigators hypothesized that patients could be categorized into two groups: 1) priority in motor functional reserve, 2) priority in cognitive functional reserve. For each group, investigators plan to randomly assign patients to experimental and control groups to demonstrate the efficacy of different rTMS protocols based on functional reserves compared to conventional high-frequency rTMS applied to the bilateral M1. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT06037590 -
A Pilot Comparative Bioavailability Study of Levodopa Administered Via Levodopa Cyclops™ Relative to INBRIJA®
|
Phase 1 | |
| Enrolling by invitation |
NCT04799418 -
STEM-PD Open Label Extension (OLE)
|
N/A | |
| Not yet recruiting |
NCT06074393 -
Caregiving in Advanced PD: A Tailored Support Group
|
N/A | |
| Completed |
NCT05699161 -
Adipose-derived Stromal Vascular Fraction Cells to Treat Parkinson
|
Phase 1/Phase 2 | |
| Not yet recruiting |
NCT05599659 -
The Calgary Movement Disorders Advanced Care Pilot Program
|
N/A | |
| Completed |
NCT04140708 -
Effects of Exercise on Glymphatic Functioning and Neurobehavioral Correlates in Parkinson's Disease
|
N/A | |
| Recruiting |
NCT03924414 -
Trial of Parkinson's And Zoledronic Acid
|
Phase 4 | |
| Recruiting |
NCT06203106 -
NYSCF Scientific Discovery Biobank
|
||
| Not yet recruiting |
NCT06400017 -
Mechanism and Application of DBS in the Treatment of PD
|
N/A | |
| Recruiting |
NCT04797611 -
STEM-Parkinson's Disease
|
N/A | |
| Not yet recruiting |
NCT06174948 -
The Use of the CUE1 in People With Parkinson's Disease and Related Disorders
|
N/A | |
| Recruiting |
NCT05934747 -
Aim 3 Particle Swarm Optimization PIGD
|
N/A | |
| Enrolling by invitation |
NCT04701177 -
Digitally-enhanced, Decentralized, Multi-omics Observational Cohort
|
||
| Recruiting |
NCT05962489 -
Sleep-specific DBS Therapy in Parkinson's Disease
|
N/A | |
| Recruiting |
NCT05931692 -
Virtual Reality and Fear of Falling in Parkinson's Disease
|
||
| Recruiting |
NCT04468919 -
Optimizing BCI-FIT: Brain Computer Interface - Functional Implementation Toolkit
|
N/A | |
| Completed |
NCT04925622 -
Complex Eye Movements in Parkinson's Disease and Related Movement Disorders
|
||
| Recruiting |
NCT04214509 -
LIPAD - LRRK2 International Parkinson's Disease Study
|
||
| Active, not recruiting |
NCT05677633 -
Biomarker Validation Following Sargramostim Treatment in Parkinson's Disease
|
Phase 1 | |
| Recruiting |
NCT06247423 -
High-frequency Alternating Current Stimulation for Tremor in Parkinson's Disease.
|
N/A |